Daily non-political popular news in brief.
Women on hormone therapy regain emotion response
10-16-2006 · EurekAlert!Older women on hormone therapy are more sensitive to negative events, confirming speculation that age-related estrogen loss affects the brain's ability to process emotion, an Oregon Health & Science University study shows. Researchers found that hormone therapy appears to reverse the age-related loss of arousal to negative emotional events experienced by the elderly. It also points to specific changes in the brain's arousal system, in the regions that process emotion, and intensification of negative emotions.
Read more »
Keywords: women, hormone, therapy, regain, emotion, response
« Previous | Next »
Similar news on "Women on hormone therapy regain emotion response":
- Black cohosh does not relieve menopausal hot flashes, Group Health researchers find
12-18-2006 · EurekAlert!
The herbal supplement black cohosh does not relieve hot flashes among women going through menopause. In this double-blinded randomized controlled trial of 351 women, researchers found no significant difference between the numbers of hot flashes in women taking various forms of black cohosh compared to women taking a placebo. Hormone therapy, on the other hand, significantly reduced the frequency of hot flashes.
Similar news · Read more »
- Reducing cardiovascular disease risk factors when discontinuing hormone replacement therapy
05-15-2007 · EurekAlert!
Hormone replacement therapy (HRT) can reduce many cardiovascular disease (CVD) risks, but many women have stopped using HRT due to reports that HRT may increase the risk of breast cancer and heart disease. In a study published in the June issue of the American Journal of Preventive Medicine, researchers from the University of Pittsburgh Graduate School of Public Health examined whether the increased CVD risk from stopping HRT could be minimized by lifestyle change intervention.
Similar news · Read more »
- IMS updated recommendations on postmenopausal hormone therapy
05-16-2007 · EurekAlert!
The Updated Recommendations express the views of the International Menopause Society on the principles of hormone therapy in the peri- and postmenopausal periods. New data and re-analyses of older studies by women's age show that, for most women, the potential benefits of hormone therapy given for a clear indication are many and the risks are few when initiated within a few years of menopause.
Similar news · Read more »
- Estrogen therapy in younger postmenopausal women linked to less plaque in arteries
06-20-2007 · EurekAlert!
New results from a substudy of the Women's Health Initiative (WHI) Estrogen-Alone Trial show that younger postmenopausal women who take estrogen-alone hormone therapy have significantly less buildup of calcium plaque in their arteries compared to their peers who did not take hormone therapy.
Similar news · Read more »
- Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use
01-15-2008 · EurekAlert!
Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
Similar news · Read more »
- Postmenopausal hormone therapy and coronary disease -- the truth of the matter
06-20-2007 · EurekAlert!
The results of WHI-CACS, now published in New England Journal of Medicine are very encouraging, since women who were randomized to the estrogen arm of the WHI had significantly smaller calcification scores than counterparts in the placebo arm. This study reaffirms that estrogen has a wide range of well-documented beneficial metabolic and vascular effects, provided that treatment is started early in menopause. Women can be reassured that estrogen therapy is cardioprotective at least until age 65.
Similar news · Read more »
- Research aims to identify markers for menopausal women at risk for deadly blood clot
08-08-2007 · EurekAlert!
In women, hormone therapy is a risk factor for venous thrombosis, a blood clot forming deep inside the vein. Although the disorder is rare, it increases exponentially during menopause and can be deadly. Hormone trials conducted thus far, focusing on proteins in blood coagulation, have not yet led to a risk profile, precluding identification of women at risk. Mayo Clinic researchers have now developed a novel concept that uses blood platelets to define thrombotic risk.
Similar news · Read more »
- Anti-inflammatory drugs interact with HRT, and more
05-21-2007 · EurekAlert!
Any cardio protective effect of hormone replacement therapy may be inhibited if women are taking a particular type of non-steroidal anti-inflammatory pain killer, report researchers led by Garret FitzGerald from University of Pennsylvania in a paper published this week in PLoS Medicine.
Similar news · Read more »
- Monkey studies parallel WHI findings, point to importance
06-25-2007 · EurekAlert!
Studies in female monkeys helped raise important questions about hormone therapy that were addressed in a Women's Health Initiative study reported last week in the New England Journal of Medicine. The animal research, conducted at the Wake Forest University Primate Center, also suggests the role that stress can play in heart disease development and point to the need for early prevention of heart disease.
Similar news · Read more »
- Grapes, soy and kudzu blunt some menopausal side effects
08-08-2007 · EurekAlert!
Menopausal women are at relatively high risk for memory loss, hypertension and diabetes. A decade ago, the standard treatment for these problems was long-term hormone replacement therapy. Since then, studies have shown that extensive use of HRT is associated with significant adverse effects. As a result, alternatives have been sought. One research lab investigating grape, soy and kudzu has found they can blunt cognitive loss, hypertension and insulin resistance in an experimental model.
Similar news · Read more »
